---
title: "Tango Therapeutics, Inc. Stock 12‑Month Price Target Raised to $27.4, Implies 7% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286444484.md"
description: "Tango Therapeutics, Inc. has seen its stock's average price target raised from $23.9 to $26, indicating a potential upside of approximately 2%. Analysts' forecasts range from $16 to $40 per share. The consensus rating remains a \"Buy\" from 12 analysts, with 10 Buys and 2 Holds. This information is based on estimates from 10 analysts and reflects the latest market insights."
datetime: "2026-05-14T16:20:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286444484.md)
  - [en](https://longbridge.com/en/news/286444484.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286444484.md)
---

# Tango Therapeutics, Inc. Stock 12‑Month Price Target Raised to $27.4, Implies 7% Upside

-   According to estimates from 10 analysts, Tango Therapeutics, Inc. stock's average price target has risen from $23.9 to $26, with forecasts ranging from $16 to $40 per share
-   Based on the May 13 closing price, the updated target implies approximately 2% potential upside
-   Consensus rating remains at “Buy” across 12 covering analysts, with 10 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Tango Therapeutics, Inc. on the , and track all previous and future analyst recommendations for Tango Therapeutics, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TNGX.US](https://longbridge.com/en/quote/TNGX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Vanguard Group Inc. Has $59.81 Million Holdings in Tango Therapeutics, Inc. $TNGX](https://longbridge.com/en/news/286550878.md)
- [Do Wall Street Analysts Like PTC Inc. Stock?](https://longbridge.com/en/news/286906040.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Capstone Companies, Inc. announces Execution of Binding Letter of Intent with eBliss Global, Inc. | CAPC Stock News](https://longbridge.com/en/news/286782166.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)